HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Christine Bayer Selected Research
Christine Bayer Research Topics
Disease
16
Neoplasms (Cancer)
08/2017 - 02/2008
14
Hypoxia (Hypoxemia)
01/2017 - 05/2007
8
Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2017 - 05/2007
6
Squamous Cell Carcinoma of Head and Neck
08/2017 - 07/2007
3
Neoplasm Metastasis (Metastasis)
08/2017 - 12/2014
3
Head and Neck Neoplasms (Head and Neck Cancer)
08/2017 - 06/2011
3
Carcinoma (Carcinomatosis)
12/2014 - 07/2007
Drug/Important Bio-Agent (IBA)
8
pimonidazole
IBA
01/2017 - 03/2008
5
Cisplatin (Platino)
FDA Link
Generic
08/2017 - 02/2008
5
Proteins (Proteins, Gene)
FDA Link
01/2016 - 05/2007
5
Plasminogen Activator Inhibitor 1
IBA
11/2012 - 05/2007
4
fluoromisonidazole
IBA
01/2017 - 06/2011
4
Plasminogen Inactivators
IBA
11/2012 - 05/2007
4
bisbenzimide ethoxide trihydrochloride (Hoechst 33342)
IBA
11/2012 - 04/2011
3
Biomarkers (Surrogate Marker)
IBA
08/2017 - 03/2014
3
DNA (Deoxyribonucleic Acid)
IBA
01/2016 - 12/2014
3
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
11/2012 - 03/2008
2
Oxygen (Dioxygen)
IBA
01/2017 - 05/2007
2
5- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamide
IBA
05/2015 - 01/2012
2
Heat-Shock Proteins (Heat-Shock Protein)
IBA
05/2015 - 01/2012
2
HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)
IBA
06/2014 - 03/2014
2
Plasminogen
IBA
03/2008 - 05/2007
1
Ligands
IBA
08/2017
1
Chemokine Receptors
IBA
08/2017
1
Eosine Yellowish-(YS) (Eosin)
IBA
01/2017
1
Hematoxylin (Haematoxylon)
IBA
01/2017
1
Radiation-Sensitizing Agents
IBA
05/2015
1
Suspensions
IBA
06/2014
1
Antigens
IBA
11/2012
1
Enzymes
IBA
11/2012
1
Immunosorbents
IBA
11/2012
1
Growth Factor Receptors
IBA
01/2012
1
tanespimycin (17AAG)
IBA
01/2012
1
Transforming Growth Factor beta1 (TGF beta 1)
IBA
02/2010
1
Small Interfering RNA (siRNA)
IBA
02/2010
1
Pharmaceutical Preparations
IBA
02/2008
1
Tirapazamine (SR 4233)
IBA
02/2008
1
Messenger RNA (mRNA)
IBA
05/2007
1
Urokinase-Type Plasminogen Activator (Urokinase)
FDA Link
05/2007
1
Urokinase Plasminogen Activator Receptors
IBA
05/2007
Therapy/Procedure
7
Radiotherapy
06/2014 - 07/2007
4
Chemoradiotherapy
08/2017 - 12/2014
3
Therapeutics
01/2017 - 06/2011
1
Drug Therapy (Chemotherapy)
08/2017
1
Adjuvant Radiotherapy
08/2017
1
Injections
02/2008